Literature DB >> 3415875

Propranolol treatment in children with tetralogy of Fallot alters the response to isoprenaline after surgical repair.

C Barazzone1, C Jaccard, M Berner, P Dayer, J C Rouge, I Oberhansli, B Friedli.   

Abstract

When propranolol is given to prevent hypoxaemic episodes in children with tetralogy of Fallot who are awaiting operation it is advisable to continue the treatment until shortly before the induction of anaesthesia. Because catecholamines are often required to maintain adequate cardiac output after surgical correction the effect of preoperative treatment with beta blockers on the response to isoprenaline after the operation was investigated in nine children given propranolol before operation and nine who were not. They were studied three and 24 hours after cardiopulmonary bypass. The haemodynamic response to increasing doses of infused isoprenaline was monitored. Immediately after cardiopulmonary bypass the response to isoprenaline was significantly blunted in the patients who had been given propranolol before operation. Their dose-response curve lay to the right of that for patients not given propranolol, and this indicates competitive inhibition. Propranolol concentrations in the blood and myocardium correlated significantly with the heart rate response to isoprenaline. Twenty four hours after operation the isoprenaline response was similar in both groups and concentrations of propranolol in the blood were minimal or undetectable. beta Blockers given up to the time of operation significantly altered the postoperative response to catecholamines.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3415875      PMCID: PMC1216539          DOI: 10.1136/hrt.60.2.156

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  16 in total

Review 1.  Clinical pharmacology of propranolol.

Authors:  A S Nies; D G Shand
Journal:  Circulation       Date:  1975-07       Impact factor: 29.690

2.  Plasma and atrial propranolol after preoperative withdrawal.

Authors:  A Romagnoli; A S Keats
Journal:  Circulation       Date:  1975-12       Impact factor: 29.690

3.  Time required for complete recovery from chronic propranolol therapy.

Authors:  S L Faulkner; J T Hopkins; R C Boerth; J L Young; L V Jellett; A S Nies; H W Bender; D G Shand
Journal:  N Engl J Med       Date:  1973-09-20       Impact factor: 91.245

4.  Propranolol and cardiac surgery.

Authors:  J F Viljoen; F G Estafanous; G A Kellner
Journal:  J Thorac Cardiovasc Surg       Date:  1972-11       Impact factor: 5.209

5.  A standardized isoproterenol sensitivity test. The effects of sinus arrhythmia, atropine, and propranolol.

Authors:  C R Cleaveland; R E Rangno; D G Shand
Journal:  Arch Intern Med       Date:  1972-07

6.  Plasma propranolol levels in adults with observations in four children.

Authors:  D G Shand; E M Nuckolls; J A Oates
Journal:  Clin Pharmacol Ther       Date:  1970 Jan-Feb       Impact factor: 6.875

7.  Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 10. Beta-adrenoceptor blockade and coronary artery surgery.

Authors:  Y Oka; W Frishman; R M Becker; A Kadish; J Strom; M Matsumoto; L Orkin; R Frater
Journal:  Am Heart J       Date:  1980-02       Impact factor: 4.749

8.  Plasma propranolol levels in the quaniitative assessment of beta-adrenergic blockade in man.

Authors:  D J Coltart; D G Shand
Journal:  Br Med J       Date:  1970-09-26

9.  Effects of hypothermia on propranolol kinetics.

Authors:  R G McAllister; D W Bourne; T G Tan; J L Erickson; C C Wachtel; E P Todd
Journal:  Clin Pharmacol Ther       Date:  1979-01       Impact factor: 6.875

10.  Assessment of beta-adrenoceptor blockade during anesthesia in humans: use of isoproterenol dose-response curves.

Authors:  J Dagnino; C Prys-Roberts
Journal:  Anesth Analg       Date:  1985-03       Impact factor: 5.108

View more
  2 in total

1.  Incidence of adverse events requiring intervention after initiation of oral beta-blocker in pediatric cardiac intensive care patients.

Authors:  Jolie Britt; Brady S Moffett; Ronald A Bronicki; Paul A Checchia
Journal:  Pediatr Cardiol       Date:  2014-04-10       Impact factor: 1.655

2.  Control of cytokinesis by β-adrenergic receptors indicates an approach for regulating cardiomyocyte endowment.

Authors:  Honghai Liu; Cheng-Hai Zhang; Niyatie Ammanamanchi; Sangita Suresh; Christopher Lewarchik; Krithika Rao; Gerrida M Uys; Lu Han; Maryline Abrial; Dean Yimlamai; Balakrishnan Ganapathy; Christelle Guillermier; Nathalie Chen; Mugdha Khaladkar; Jennifer Spaethling; James H Eberwine; Junhyong Kim; Stuart Walsh; Sangita Choudhury; Kathryn Little; Kimberly Francis; Mahesh Sharma; Melita Viegas; Abha Bais; Dennis Kostka; Jun Ding; Ziv Bar-Joseph; Yijen Wu; Vijay Yechoor; Mousumi Moulik; Jennifer Johnson; Jacqueline Weinberg; Miguel Reyes-Múgica; Matthew L Steinhauser; Bernhard Kühn
Journal:  Sci Transl Med       Date:  2019-10-09       Impact factor: 17.956

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.